Nouscom poster presentation on NOUS-PEV Personalized Neoantigen Cancer Vaccine selected for poster presentation at SITC 2022

 In Presentations

PRESENTATION TITLE: Nouscom poster presentation on NOUS-PEV Personalized Neoantigen Cancer Vaccine selected for poster presentation at SITC 2022

Read more
Recent Posts
error: Content is protected !!!
Nouscom poster presentation of Full Phase 1 Data of NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Immunotherapy for the Treatment of dMMR/MSI-H Solid Tumors, at ASCO 2022Presentations
Nouscom presentation of a Late-Breaking Abstract on Translational Phase 1b data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy, at AACR 2023Presentations